XML 32 R14.htm IDEA: XBRL DOCUMENT
v3.19.3

Equity | 9 Months Ended
--- | ---
Sep. 30, 2019
Equity [Abstract] |
EQUITY | EQUITY Amendment to Articles of Incorporation On January 10, 2018, we filed with the Maryland Department of Assessments and Taxation Articles Supplementary to reclassify and designate 6,500,000 shares of our authorized and unissued shares of capital stock as shares of Series B Preferred Stock (as defined below). The reclassification decreased the number of shares classified as common stock from 98,000,000 to 91,500,000. Stockholders’ Equity As of September 30, 2019, there were 6,500,000 shares of Series B Preferred Stock (as defined below), par value $0.001 per share, authorized, with 3,465,527 shares issued and outstanding worth an aggregate liquidation value of approximately $86.6 million; and 91,500,000 shares of common stock, par value $0.001 per share, authorized, with 20,888,075 shares issued and outstanding. As of December 31, 2018, there were 6,500,000 shares of Series B Preferred Stock (as defined below), par value $0.001 per share, authorized, with 1,144,393 shares issued and outstanding worth an aggregate liquidation value of approximately $28.6 million; and 91,500,000 shares of common stock, par value $0.001 per share, authorized, with 17,891,340 shares issued and outstanding. Non-Controlling Interests in Operating Partnership We consolidate our Operating Partnership, which is a majority-owned partnership. As of September 30, 2019, and December 31, 2018, we owned approximately 98.6% and 96.9%, respectively, of the outstanding OP Units. On or after 12 months after becoming a holder of OP Units, each limited partner, other than the Company, has the right, subject to the terms and conditions set forth in the partnership agreement of the Operating Partnership, to require the Operating Partnership to redeem all or a portion of such units in exchange for cash or, at the Company’s option, shares of our common stock on a one-for-one basis. The cash redemption per OP Unit would be based on the market price of our common stock at the time of redemption. A limited partner will not be entitled to exercise redemption rights if the delivery of common stock to the redeeming limited partner would breach restrictions on the ownership of common stock imposed under our charter and other limitations thereof. The following table provides information related to OP Units tendered for redemption during 2019:
Fiscal Year |  | OP Units Tendered for Redemption |  | Shares of Common Stock Issued |  | OP Units Redeemed with Cash |  | Aggregate Cash Payment |  | Aggregate Cash Paid per OP Unit
Three months ended September 30, 2019 |  | 0 |  | 0 |  | 0 |  | $ | — |  |  | $ | — |
Nine months ended September 30, 2019 |  | 570,879 |  | 570,879 |  | 0 |  | — |  |  | — |
Regardless of the rights described above, the Operating Partnership will not have an obligation to issue cash to a unitholder upon a redemption request if the Company elects to redeem the OP Units for shares of its common stock. When a non-controlling unitholder redeems OP Units and the Company elects to satisfy that redemption through the issuance of common stock, non-controlling interest in the Operating Partnership is reduced, and stockholders’ equity is increased. The Operating Partnership is required to make distributions on each OP Unit in the same amount as those paid on each share of the Company’s common stock, with the distributions on the OP Units held by the Company being utilized to make distributions to the Company’s common stockholders. As of September 30, 2019, and December 31, 2018, there were 288,303 and 570,879 OP Units held by non-controlling limited partners outstanding, respectively. Registration Statement On March 30, 2017, we filed a universal registration statement on Form S-3 (File No. 333-217042) with the SEC (the “2017 Registration Statement”) to replace our previous registration statement, which expired on April 1, 2017. The 2017 Registration Statement, which was declared effective by the SEC on April 12, 2017, permits us to issue up to an aggregate of $300.0 million in securities, consisting of common stock, preferred stock, warrants, debt securities, depository shares, subscription rights, and units, including through separate, concurrent offerings of two or more of such securities. Through September 30, 2019, we have issued a total of 7,821,886 shares of common stock (excluding 1,215,565 shares of common stock issued in exchange for certain OP Units that were tendered for redemption) for gross proceeds of approximately $96.1 million, and 3,475,047 shares of Series B Preferred Stock (as defined below) for gross proceeds of approximately $85.6 million under the 2017 Registration Statement. 2019 Equity Issuances Series B Preferred Stock On May 31, 2018, we filed a prospectus supplement with the SEC for a continuous public offering of up to 6,000,000 shares of our newly-designated 6.00% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”) at an offering price of $25.00 per share for gross proceeds of up to $150.0 million and expected net proceeds, after deducting Selling Commissions, Dealer-Manager Fees, and estimated expenses of the offering payable by us, of up to approximately $131.3 million, assuming all shares of the Series B Preferred Stock are sold in the offering. The Series B Preferred Stock is being offered on a continuous, “reasonable best efforts” basis by Gladstone Securities, the dealer-manager for the offering. See Note 6, “Related-Party Transactions—Gladstone Securities—Dealer-Manager Agreement,” for a discussion of the fees and commissions to be paid to Gladstone Securities in connection with the offering of the Series B Preferred Stock. The following table provides information on sales of the Series B Preferred Stock that occurred during the three and nine months ended September 30, 2019 (dollars in thousands, except per-share amounts):
Period |  | Number of Shares Sold |  | Weighted-average Offering Price per Share |  | Gross Proceeds |  | Net Proceeds(1)
Three months ended September 30, 2019 |  | 831,579 |  | $ | 24.64 |  |  | $ | 20,487 |  |  | $ | 18,711 |
Nine months ended September 30, 2019 |  | 2,330,654 |  | 24.68 |  |  | 57,529 |  |  | 52,440 |
(1) | Net of selling commissions and dealer-manager fees borne by us.
In addition, during the three and nine months ended September 30, 2019, 2,120 and 9,520 shares, respectively, of the Series B Preferred Stock were tendered for redemption at a cash redemption price of $22.50 per share. As a result, we paid total redemption costs of approximately $48,000 and $214,000, respectively to redeem and retire these shares. As of September 30, 2019, excluding Selling Commissions and Dealer-Manager Fees, we have incurred approximately $1.2 million of total costs related to this offering, which are initially recorded as deferred offering costs (included within Other assets, net on the accompanying Condensed Consolidated Balance Sheets) and are applied against the gross proceeds received from the offering through additional paid-in capital as shares of the Series B Preferred Stock are sold. See Note 11, “Subsequent Events—Equity Activity—Series B Preferred Stock,” for sales of Series B Preferred Stock completed subsequent to September 30, 2019. The offering of the Series B Preferred Stock will terminate on the date that is the earlier of either June 1, 2023 (unless terminated earlier or extended by our Board of Directors), or the date on which all 6,000,000 shares offered are sold (the “Termination Date”). There is currently no public market for shares of the Series B Preferred Stock; however, we intend to apply to list the Series B Preferred Stock on Nasdaq or another national securities exchange within one calendar year after the offering’s Termination Date, though there can be no assurance that a listing will be achieved in such timeframe, or at all. Common Stock Secondary Offering In June 2019, we completed a public offering of 2,000,000 shares of our common stock at a public offering price of $11.73 per share, resulting in gross proceeds of approximately $23.5 million and net proceeds (after deducting underwriting discounts and direct offering expenses borne by us) of approximately $22.3 million. In July 2019, the underwriters exercised a portion of the over-allotment option in connection with the offering, and, as a result, we issued an additional 277,297 shares of our common stock, resulting in gross proceeds of approximately $3.3 million and net proceeds (after deducting underwriting discounts and direct offering expenses borne by us) of approximately $3.1 million. At-the-Market Program On August 7, 2015, we entered into equity distribution agreements (commonly referred to as “at-the-market agreements”) with Cantor Fitzgerald & Co. and Ladenburg Thalmann & Co., Inc. (each a “Sales Agent”), under which we may issue and sell, from time to time and through the Sales Agents, shares of our common stock having an aggregate offering price of up to $30.0 million (the “ATM Program”). The following table provides information on shares of common stock sold under the ATM Program during 2019 (dollars in thousands, except per-share amounts):
Period |  | Number of Shares Sold |  | Weighted-average Offering Price Per Share |  | Gross Proceeds |  | Net Proceeds(1)
Three months ended September 30, 2019 |  | 78,008 |  | $ | 12.01 |  |  | $ | 937 |  |  | $ | 923 |
Nine months ended September 30, 2019 |  | 148,559 |  | 12.32 |  |  | 1,830 |  |  | 1,802 |
(1) | Net of underwriting commissions and discounts.
Through September 30, 2019, we have issued and sold a total of 1,744,150 shares of our common stock under the ATM Program at an average sales price of $12.82 per share for gross proceeds of approximately $22.4 million and net proceeds of approximately $22.0 million. Distributions The per-share distributions to preferred and common stockholders declared by our Board of Directors and paid by us (except as noted) during the three and nine months ended September 30, 2019 and 2018 are reflected in the table below.
|  | For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
Issuance |  | 2019 |  | 2018 |  | 2019 |  | 2018
Series A Term Preferred Stock(1) |  | $ | 0.3984375 |  |  | $ | 0.3984375 |  |  | $ | 1.1953125 |  |  | $ | 1.1953125 |
Series B Preferred Stock(2) |  | 0.375 |  |  | 0.375 |  |  | 1.125 |  |  | 0.500 |
Common Stock(3) |  | 0.13365 |  |  | 0.13305 |  |  | 0.40050 |  |  | 0.39870 |
(1) | Treated similar to interest expense on the accompanying Condensed Consolidated Statements of Operations and Comprehensive Income.
(2) | Of the dividends declared on the Series B Preferred Stock by our Board of Directors on July 9, 2019, approximately $433,000 was paid (as scheduled) by us on October 3, 2019. The resulting dividend payable is included within Accounts payable and accrued expenses on the accompanying Condensed Consolidated Balance Sheets as of September 30, 2019.
(3) | The same amounts were paid as distributions on each OP Unit held by non-controlling limited partners.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration